An Efficacy and Safety Study of Omega-3 Free Fatty Acids (Epanova™) for the Maintenance of Symptomatic Remission in Subjects With Crohn's Disease
Clinical trial NCT00074542 · COMPLETED
Trial details
- NCT number
- NCT00074542
- Sponsor
- Tillotts Pharma AG
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Enrollment
- 364
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.